Cardio Diagnostics Holdings, Inc. (CDIOW) — Quarterly Report

Key Insights

• Company is classified as a smaller reporting company and emerging growth company, indicating early-stage development with limited financial scale and ongoing operations establishment.
• The filing shows multiple equity instruments outstanding including common stock, warrants, and stock options, suggesting potential significant dilution for existing shareholders from future exercises.
• Company maintains dual listings on NASDAQ for both common stock (CDIO) and redeemable warrants (CDIOW), indicating active capital markets access, though as a non-accelerated filer this represents a smaller public company.
• The presence of At-The-Market (ATM) issuance agreements suggests the company is utilizing equity financing to fund operations, which could signal ongoing liquidity needs and cash burn concerns.